Programme 3

EPSCs for Genomic Medicine of Immune Disease

Team

Professor Chak Sing Lau

HKU
Leader

Dr. Bo Gao

HKU
Co-Pls & Collaborators

Dr. Philip Li

HKU
Co-Pls & Collaborators

Dr. Vera Chan

HKU
Co-Pls & Collaborators

Programme Summary

CTSCB will use the EPSC technology to link genotype to phenotype through genetically defined stem cell-based models of human immune disease. Patient-derived EPSCs and isogenic EPSCs carrying engineered immune susceptibility mutations are used for the development of personalized stem cell-based phenotyping assays

Programme Description

  • Stem cells for studying immunological disorders
  • Drug candidates for immunological disorders
Publications

Projects